DESCRIPTION

Used for the quantitative determination of Anti-HRSV F/Fusion glycoprotein F0 Human IgG concentration in serum and plasma.

PRINCIPLE OF THE ASSAY

This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant HRSV F/Fusion glycoprotein F0 has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Anti-HRSV F/Fusion glycoprotein F0 Human IgG present is bound by the immobilized protein. After washing away any unbound substances, a biotin-labeled Mouse Anti-Human IgG antibody is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-HRSV F/Fusion glycoprotein F0 Human IgG bound in the initial step. The color development is stopped and the intensity of the color is measured.

PRECISION

Intra-Assay Precision (Precision within an assay): <10% Three samples of known concentration were tested sixteen times on one plate to assess intra-assay precision. Inter-Assay Precision (Precision between assays): <15% Three samples of known concentration were tested in twenty four separate assays to assess inter-assay precision.

RECOVERY

LINEARITY